GlycA Is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients With Type 2 Diabetes

Inflammation - United States
doi 10.1007/s10753-014-0107-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Visfatin as a Novel Marker of Endothelial Dysfunction in Patients With Type 2 Diabetes

International Journal of Contemporary Medical Research [IJCMR]
2018English

Management of Hospitalized Type 2 Diabetes Mellitus Patients

Journal of Translational Internal Medicine
2016English

The Prevalence of Acromegaly in Hospitalized Patients With Type 2 Diabetes

Endocrine Journal
EndocrinologyMetabolismDiabetes
2015English

Asthma Patients Hospitalized With Influenza Lack Mucosal and Systemic Type 2 Inflammation

2016English

Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Critically Ill and Non-Critically Ill AIDS Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Inflammation Biomarkers and Delirium in Critically Ill Patients: New Insights?

Critical Care
Critical CareIntensive Care Medicine
2014English

Interleukins as a Marker of Inflammation in Diabetic Foot Syndrome and Type 2 Diabetes Mellitus

Bezmialem Science
2019English

A Novel Equipment Bridge for Helicopter Transport of Critically Ill Patients

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy